Indegene Ltd.

₹562.25

Indegene Ltd.

₹562.25

₹562.25

4.15 (0.74%) - 30 Apr 2025 01:07 PM

About Company

Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its solutions enable life sciences companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner. It achieves this by combining over two decades of healthcare domain expertise and fit-for purpose technology. 

Market Cap. ₹13,395 Cr.
52 Week - High/Low ₹736/470
P/E Ratio 73.63
P/B Ratio 14.04
Enterprise Value ₹13,429 Cr.
ROE % 16.22
RSI Value 47.95
EMA 50 566.89
EMA 200 590.17
Market Cap. ₹13,395 Cr.
52 Week - High/Low ₹736/470
P/E Ratio 32.83
P/B Ratio 9.37
Enterprise Value ₹13,636 Cr.
ROE % 27.56
RSI Value 47.95
EMA 50 566.89
EMA 200 590.17

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.